Similar articles

• The need for change: Lessons learned from Food and Drug Administration-approved peanut oral immunotherapy.

  Mustafa SS, Mack DP. Mustafa SS, et al. Ann Allergy Asthma Immunol. 2023 May;130(5):542-543. doi: 10.1016/j.anai.2023.01.031. Ann Allergy Asthma Immunol. 2023. PMID: 37137601 No abstract available.
• Anaphylaxis during Peanut Oral Immunotherapy: Looking beyond dose escalation.

  Blackman AC, Staggers KA, Anagnostou A. Blackman AC, et al. Pediatr Allergy Immunol. 2022 Dec;33(12):e13888. doi: 10.1111/pai.13888. Pediatr Allergy Immunol. 2022. PMID: 36564873 No abstract available.
• Current opinion and review on peanut oral immunotherapy.

  Deol S, Bird JA. Deol S, et al. Hum Vaccin Immunother. 2014;10(10):3017-21. doi: 10.4161/hv.32190. Hum Vaccin Immunother. 2014. PMID: 25483680 Free PMC article. Review.
• Quality of life improves significantly after real-world oral immunotherapy for children with peanut allergy.

  Blackman AC, Staggers KA, Kronisch L, Davis CM, Anagnostou A. Blackman AC, et al. Ann Allergy Asthma Immunol. 2020 Aug;125(2):196-201.e1. doi: 10.1016/j.anai.2020.03.028. Epub 2020 Apr 8. Ann Allergy Asthma Immunol. 2020. PMID: 32278075
• Oral immunotherapy for treatment of peanut allergy.

  Dunlop JH. Dunlop JH. J Investig Med. 2020 Aug;68(6):1152-1155. doi: 10.1136/jim-2020-001422. Epub 2020 Jul 14. J Investig Med. 2020. PMID: 32665367 Review.